ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform

Million in Gross Claims with Expanding Settlement Activity Across Multiple Insurance CarriersActive Negotiations Support Estimated $50–$60 ...
Seeking Alpha

ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories

Proposed transaction aims to deliver near-term value for ProPhase shareholders, long-term growth for ABL, and create a global, innovation-driven company. Company to hold a virtual conference call ...
Seeking Alpha

ProPhase Labs signals $50M net collection target and strategic initiatives as Crown Medical litigation advances

Ted Karkus, Chairman & CEO, opened by emphasizing the critical importance of shareholder voting on the company's proxy, noting, "If you do not vote for our proxy, you are putting our company in harm's ...
Business Insider

ProPhase Labs Engages RedChip Companies to Lead Investor Relations Efforts

UNIONDALE, NY, Oct. 28, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics, and consumer products company, today announced ...
Nasdaq

ProPhase Labs Moves Up From Pink Sheets To OTC Market

(RTTNews) - ProPhase Labs, Inc. (PRPH) announced that its common stock has successfully uplisted from the Pink Sheets to the OTC Market, marking a step forward in the company's efforts to enhance ...